Literature DB >> 5698419

Urokinase therapy in pulmonary thromboembolism.

E Genton, P S Wolf.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 5698419     DOI: 10.1016/0002-8703(68)90161-0

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


× No keyword cloud information.
  11 in total

Review 1.  Cerebral venous sinus thrombosis.

Authors:  Shelley Renowden
Journal:  Eur Radiol       Date:  2003-10-03       Impact factor: 5.315

Review 2.  Interventional neuroradiology.

Authors:  S Renowden
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-09       Impact factor: 10.154

Review 3.  Streptokinase: a review of its clinical pharmacology, mechanism of action and therapeutic uses.

Authors:  R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1973       Impact factor: 9.546

4.  Prophylaxis of pulmonary embolism.

Authors:  N L Browse
Journal:  Br Med J       Date:  1970-06-27

5.  Early rate of resolution of major pulmonary embolism. A study of angiographic and haemodynamic changes occurring in the first 24 to 48 hours.

Authors:  I G McDonald; J Hirsh; G S Hale
Journal:  Br Heart J       Date:  1971-07

6.  Comparison of streptokinase and heparin in treatment of isolated acute massive pulmonary embolism.

Authors:  G A Miller; G C Sutton; I H Kerr; R V Gibson; M Honey
Journal:  Br Med J       Date:  1971-06-19

Review 7.  Pulmonary embolism: current therapeutic concepts.

Authors:  D A Tibbutt; C N Chesterman
Journal:  Drugs       Date:  1976       Impact factor: 9.546

8.  Resolution of experimental pulmonary emboli with heparin and streptokinase in different dosage regimens.

Authors:  J Hirsh; J F Cade; E Regoeczi; M Gent; M R Buchanan; D M Hynes
Journal:  J Clin Invest       Date:  1974-10       Impact factor: 14.808

9.  Comparison of the effects of streptokinase and heparin on the early rate of resolution of major pulmonary embolism.

Authors:  J Hirsh; I G McDonald; G A Hale; E F O'Sullivan; V M Jelinek
Journal:  Can Med Assoc J       Date:  1971-03-20       Impact factor: 8.262

10.  Thrombolytic therapy for pulmonary embolism.

Authors:  Zhiliang Zuo; Jirong Yue; Bi Rong Dong; Taixiang Wu; Guan J Liu; Qiukui Hao
Journal:  Cochrane Database Syst Rev       Date:  2021-04-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.